Microbiological Testing & Facility Support for Personal Care Products
In the personal care industry, microbiological quality is essential to product safety, regulatory compliance, and consumer trust. At Q Laboratories, we specialize in supporting manufacturers of cosmetics, skincare, haircare, and hygiene products with microbiological testing and facility validation services. Whether you’re launching a new formulation or maintaining GMP compliance, our team delivers the expertise and precision you need to protect your brand and meet global standards..
Our Capabilities
We provide a comprehensive suite of analytical chemistry services specifically tailored to meet the unique needs of personal care formulations. Below is a brief, though not exhaustive, overview of our offerings:
We offer comprehensive microbiological services to support every stage of your product lifecycle:
- Raw Materials, Intermediates, Finished Goods
- Quality Control / Release Testing
- Stability Studies
- R&D / Formulation Support
- Suitability / Neutralization Studies
- Microbial Limits Testing (USP <61>)
- Specified Organism Testing (USP <62>, <60>)
- Antimicrobial Effectiveness Testing (USP <51>, ISO, PCPC)
- Microbial Identification
Ensure your manufacturing environment meets the highest standards for cleanliness and control:
- Environmental Monitoring
- Viable Air Sampling
- Surface Swabs
- Water System Validation & Monitoring
- Cleaning Validations
- Compressed Air Testing
We utilize the Bruker MALDI Biotyper® (MALDI-TOF) for high-resolution microbial identification. This technology supports international validation efforts, including pathogen confirmation after initial screening.
Our specialized lab provides rapid and accurate organism identification:
- Confirmation of Positive Results
- Identification of House Isolates
- Possible Organism Banking & Long-Term Storage
Allow the user to explore a list of Personal Care testing Methodology (in alphabetical order by each grouping)
Note: This overview is not exhaustive. For detailed information on client-specific protocols or proprietary Q Labs methodologies, please contact us directly to discuss your specific requirements.
Dedicated Microbial Identification Lab with Cutting-Edge Technology
We utilize the Bruker MALDI Biotyper® (MALDI-TOF) for high-resolution microbial identification. This technology supports international validation efforts, including pathogen confirmation after initial screening.
Our specialized lab provides rapid and accurate organism identification:
- Confirmation of Positive Results
- Identification of House Isolates
- Possible Organism Banking & Long-Term Storage
Note: This overview is not exhaustive. For detailed information on client-specific protocols or proprietary Q Labs methodologies, please contact us directly to discuss your specific requirements.
| European Pharmacopeia | C. albicans 2.6.13 | |
| European Pharmacopeia | E. coli 2.6.13 | |
| European Pharmacopeia | Heterotrophic Plate Count [HPC] | |
| European Pharmacopeia | P. aeruginosa 2.6.13 | |
| European Pharmacopeia | S. aureus 2.6.13 | |
| European Pharmacopeia | Salmonella 2.6.13 | |
| European Pharmacopeia | Total Aerobic Microbial Count [TAMC] 2.6.12 | |
| European Pharmacopeia | Total Yeast and Mold Count [TYMC] 2.6.12 | |
| FDA Bacteriological Analytical Manual | B. cereus | |
| FDA Bacteriological Analytical Manual | Coliform | |
| FDA Bacteriological Analytical Manual | Listeria | |
| FDA Bacteriological Analytical Manual | Salmonella | |
| FDA Bacteriological Analytical Manual | Suitability of B. cereus | |
| FDA Bacteriological Analytical Manual | Suitability of Coliform | |
| Gram Stain | Gram Stain | |
| ISO | Detection of C. albicans 18416 | |
| ISO | Detection of E. coli 21150 | |
| ISO | Detection of P. aeruginosa 22717 | |
| ISO | Detection of S. aureus 22718 | |
| ISO | Enumeration and Detection of Aerobic Mesophilic Bacteria 21149 | |
| ISO | Enumeration of Yeast and Mould 16221 | |
| ISO | Preservative Efficacy Testing [PET] 11930:2019 | |
| ISO | Suitability of Detection of C. albicans 18416 | |
| ISO | Suitability of Detection of E. coli 21150 | |
| ISO | Suitability of Detection of P. aeruginosa 22717 | |
| ISO | Suitability of Detection of S. aureus 22718 | |
| ISO | Suitability of Enumeration and Detection of Aerobic Mesophilic Bacteria 21149 | |
| ISO | Suitability of Enumeration of Yeast and Mould 16212 | |
| PCPC | Neutralization [PET] | |
| PCPC | Preservative Efficacy Testing [PET] M-3 | |
| PCPC | Preservative Efficacy Testing [PET] M-5 | |
| PCPC | Preservative Efficacy Testing [PET] M-7 | |
| Q Laboratories SOP | General Enrichment Tests for Qualitative Detection of Aerobic Microorganisms and Fungi | |
| Q Laboratories SOP | Heterotrophic Plate Count [HPC] - Membrane Filtration (TGY) <1231> | |
| Q Laboratories SOP | Heterotrophic Plate Count [HPC] - Pour Plate (TGY) <1231> | |
| Q Laboratories SOP | Microbial/Filamentous Fungi Identification - Bruker MALDI Biotyper | |
| Q Laboratories SOP | Microbiological Examination of Environmental Surface and Air Samples (air settling plate, strip) <1116> | |
| Q Laboratories SOP | Microbiological Examination of Environmental Surface and Air Samples (contact plate) <1116> | |
| SMEWW | Coliform | |
| SMEWW | E. coli | |
| SMEWW | Fecal Coliform | |
| SMEWW | Heterotrophic Plate Count [HPC] | |
| USP | AET Neutralization <51> | |
| USP | Antimicrobial Effectiveness Test [AET] <51> | |
| USP | Antimicrobial Effectiveness Test [AET] with B. cepacia <51> | |
| USP | B. Cepacia Complex <60> | |
| USP | Bacterial Endotoxin - Kinetic Chromogenic <85> | |
| USP | Bacterial Endotoxin Test (Gel Clot) <85> | |
| USP | Bile Tolerant Gram Negative Bacteria <62> | |
| USP | C. albicans <62> | |
| USP | Clostridia <2022> | |
| USP | Clostridia <62> | |
| USP | E. coli <2022> | |
| USP | E. coli <62> | |
| USP | Enterobacterial Count (Bile Tolerant Gram Negative Bacteria) - MPN <2021> | |
| USP | Environmental Monitoring <797> | |
| USP | Growth Promotion <61> | |
| USP | P. aeruginosa <62> | |
| USP | Preparatory Testing <2021> | |
| USP | Preparatory Testing <2022> | |
| USP | Preparatory Testing <85> | |
| USP | S. aureus <2022> | |
| USP | S. aureus <62> | |
| USP | Salmonella <2022> | |
| USP | Salmonella <62> | |
| USP | Suitability of B. cepacia Complex <60> | |
| USP | Suitability of the Counting Method <61> | |
| USP | Suitability of the Test Method <62> | |
| USP | Total Aerobic Microbial Count [TAMC] <2021> | |
| USP | Total Aerobic Microbial Count [TAMC] <61> | |
| USP | Total Yeast and Mold Count [TYMC] <2021> | |
| USP | Total Yeast and Mold Count [TYMC] <61> | |
| USP | Validation of Microbial Recovery <1227> |